{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:44:57Z","timestamp":1779126297379,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K08790"],"award-info":[{"award-number":["15K08790"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26461656"],"award-info":[{"award-number":["26461656"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cca.2017.06.022","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T17:47:20Z","timestamp":1498844840000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Autoantibodies to Su\/Argonaute 2 in Japanese patients with inflammatory myopathy"],"prefix":"10.1016","volume":"471","author":[{"given":"Mariko","family":"Ogawa-Momohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.06.022_bb0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/art.1780271108","article-title":"Characterization of a new antigen-antibody system (Su) in patients with systemic lupus erythematosus","volume":"27","author":"Treadwell","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2017.06.022_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4049\/jimmunol.150.2.695","article-title":"MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus","volume":"150","author":"Treadwell","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2017.06.022_bb0015","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","article-title":"Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristine","volume":"180","author":"Satoh","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2017.06.022_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/clin.1994.1179","article-title":"Characterization of the Su antigen, a macromolecular complex of 100\/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases","volume":"73","author":"Satoh","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cca.2017.06.022_bb0025","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar1959","article-title":"Autoimmune targeting of key components of RNA interference","volume":"8","author":"Jakymiw","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2017.06.022_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.06.022_bb0035","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2017.06.022_bb0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/art.22329","article-title":"Autoantibodies to RNA helicase A: a new serologic marker of early lupus","volume":"56","author":"Yamasaki","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2017.06.022_bb0045","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/ar2621","article-title":"Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies","volume":"11","author":"Palafox S\u00e1nchez","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2017.06.022_bb0050","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Del Mercado M, Palafox-S\u00e1nchez et al., High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus, Arthritis Res. Ther. 2010; 12(2010) R6.","DOI":"10.1186\/ar2905"},{"key":"10.1016\/j.cca.2017.06.022_bb0055","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/rheumatology\/kev247","article-title":"High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis","volume":"54","author":"Muro","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2017.06.022_bb0060","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.38866","article-title":"Autoantibodies to DNA mismatch repair enzymes in polymyositis\/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis","volume":"66","author":"Muro","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2017.06.022_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2017.06.022_bb0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cca.2017.06.022_bb0075","doi-asserted-by":"crossref","first-page":"856815","DOI":"10.1155\/2013\/856815","article-title":"A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement","volume":"2013","author":"Muro","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cca.2017.06.022_bb0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ncb1334","article-title":"Disruption of GW bodies impairs mammalian RNA interference","volume":"7","author":"Jakymiw","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cca.2017.06.022_bb0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/08916934.2010.499886","article-title":"Anti-argonaute2 (Ago2\/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS)","volume":"44","author":"Ceribelli","year":"2011","journal-title":"Autoimmunity"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:29:42Z","timestamp":1692862182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117302486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":17,"alternative-id":["S0009898117302486"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.06.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to Su\/Argonaute 2 in Japanese patients with inflammatory myopathy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}